Status:
UNKNOWN
Outcome of Radiation Therapy in Urinary Bladder Squampus Cell Carcinoma
Lead Sponsor:
Assiut University
Conditions:
Urinary Bladder Squamous Cell Carcinoma
Eligibility:
All Genders
18-70 years
Brief Summary
Detection of distribution of clinico-pathological features of squamous cell carcinoma of urinary bladder and their relation to treatment outcome.
Eligibility Criteria
Inclusion
- age 18-70 .
- histologically proved urinary bladder squamous cell carcinoma.
- non-metastatic disease.
- all patients who underwent radical treatment or bladder preserving approach.
- patient with isolated urinary bladder carcinoma (no other or previous primary).
Exclusion
- age \< 18 , \> 70.
- patient not documented having bladder squamous cell carcinoma by biopsy (cystoscopic or operative).
- metastatic disease.
- patient with synchronous or metachronous double primary
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04815629
Start Date
April 1 2022
End Date
April 1 2023
Last Update
August 18 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.